The upcoming NIS 2 Directive will affect most pharmaceutical companies and medical device manufacturers. It defines minimum cybersecurity requirements for organizations, and there is significant uncertainty regarding compliance with the upcoming regulation. To address this, EXCO has developed a checklist that covers all requirements of the NIS 2 Directive and enables companies to assess their current cybersecurity status.
Tasks and implementation
- Development of a checklist covering all requirements of the NIS 2 Directive
- Assessment of an organization's current cybersecurity posture
- Basis for deriving measures to implement the Directive
- Risk assessment provided in the form of an Excel spreadsheet
Customer benefits
- Increased awareness of the scope of measures required to comply with the NIS 2 Directive
- Cybersecurity gained greater importance within the organization and moved further into the focus of management
- Implementation of training measures to build internal cybersecurity expertise
- Prioritization of the identified measures in collaboration with EXCO
Customer
Pharmaceutical company
